Literature DB >> 10093879

[Use of snake venom proteins in medicine].

K Stocker.   

Abstract

Snakes feed exclusively on freshly killed prey animals which, following their immobilization, have to be swallowed whole. Venomous snakes effect prey immobilization by injection of their venom. Snake venoms are highly concentrated, complex mixtures of individual proteins which, either as enzymes, enzyme effectors or blocking ligands, acting as single agents or in synergistic conjunction with other venom components, modify vital structures of the prey organism to destroy their biological function. Predominantly neurotoxic venoms paralyze respiratory activity by pre- or postsynaptic blockade of neuromuscular transmission. Predominantly haemocytotoxic snake venoms contain components which interact with proteins of the haemostasis, kallikrein or complement system, causing blood volume loss, hypotension or intravascular coagulation which finally lead to circulatory failure. Several isolated snake venom proteins with a known mode of action have found practical application as pharmaceutical agents, diagnostic reagents or preparative tools in the field of haemostaseology, neurobiology and complement research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093879

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  2 in total

1.  Crotalus durissus collilineatus Venom Induces TNF- α and IL-10 Production in Human Peripheral Blood Mononuclear Cells.

Authors:  Camila Bastos Ribeiro; Jéssica Cristina Dos Santos; Jacyelle Medeiros Silva; Pedro Henrique Silva de Godoi; Marta Regina Magalhães; Mônica Spadafora-Ferreira; Simone Gonçalves Fonseca; Irmtraut Araci Hoffman Pfrimer
Journal:  ISRN Inflamm       Date:  2014-01-19

Review 2.  Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.

Authors:  Raoudha Zouari-Kessentini; Najet Srairi-Abid; Amine Bazaa; Mohamed El Ayeb; Jose Luis; Naziha Marrakchi
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.